Teva Pharmaceutical Indus...

NYSE: TEVA · Real-Time Price · USD
17.61
0.07 (0.40%)
At close: Aug 15, 2025, 9:59 AM

Teva Pharmaceutical Industries Cash Flow Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Net Income
-1.96B -615M -2.41B 456M
Depreciation & Amortization
1.06B 1.15B 1.31B 1.33B
Stock-Based Compensation
123M 121M 124M 119M
Other Working Capital
-1.1B -1.67B -828M -2.27B
Other Non-Cash Items
3.09B 1.1B 2.37B 714M
Deferred Income Tax
-634M -317M -1.06B -120M
Change in Working Capital
-435M -72M 1.26B -1.7B
Operating Cash Flow
1.25B 1.37B 1.59B 798M
Capital Expenditures
-498M -526M -548M -562M
Cash Acquisitions
28M 68M 61M 1.96B
Purchase of Investments
-71M -46M -1M -47M
Sales Maturities Of Investments
40M n/a 4M 172M
Other Investing Acitivies
1.29B 1.47B 1.14B 1M
Investing Cash Flow
792M 968M 656M 1.52B
Debt Repayment
-1.64B -1.7B -1.37B -2.17B
Common Stock Repurchased
n/a n/a n/a n/a
Dividend Paid
n/a n/a n/a n/a
Other Financial Acitivies
-150M -212M -118M -6M
Financial Cash Flow
-1.79B -1.91B -1.49B -2.17B
Net Cash Flow
73M 393M 636M 21M
Free Cash Flow
749M 842M 1.04B 236M